In vivo and in vitro antiviral activity of five Tibetan medicinal plant extracts against herpes simplex virus type 2 infection

References

• Anon (1991): Tibetan Medicine Glossary. Xining, Qinghai People’s Press, pp.131–138; 276–289; 384–390; 567–574; 828–932.
   Google Scholar
• Anon (1996): Chinese Tibetan Medicine. Shanghai, Science and Technology Press of Shanghai, pp. 351–362; 445–450; 634–640; 780–785; 892–898.
   Google Scholar
• Baringer RJ, Swoveland P (1973): Recovery of herpes-simplex virus from human trigeminal ganglions. New Engl Med 288: 648–650.
   PubMed Web of Science ®Google Scholar
• Bean B (1992): Antiviral therapy: Current concept and practices. Clin Microbiol Rev 5: 14–182.
   Web of Science ®Google Scholar
• Carlucci MJ, Ciancia M, Matulewicz MC, Cerezo AS, Damonte EB (1999): Antiherpetic activity and mode of action of natural carrageenans of diverse structural types. Antivir Res 43: 93–102.
   PubMed Web of Science ®Google Scholar
• Cassady KA, Whitley RJ (1997): New therapeutic approaches to the alphaherpesvirus infections. J Antimicrob Chemother 39: 119–128.
   PubMed Web of Science ®Google Scholar
• Celum CL (2004).The interaction between herpes simplex virus and human immunodeficiency virus. Herpes 11(Suppl 1): 36A–45A.
   PubMedGoogle Scholar
• Cheng HY, Lin TC, Yang CM, Wang KC, Lin LT, Lin CC (2004): Putranjivain A from Euphorbia jolkini inhibits both virus entry and late stage of herpes simplex virus type 2 infection in vitro. J Antimicrob Chemother 53: 577–583.
   PubMed Web of Science ®Google Scholar
• Chiang LC, Chiang W, Chang MY, Ng LT (2002): Antiviral activity of Plantago major extracts and related compounds in vitro. Antivir Res 55: 53–62.
   PubMed Web of Science ®Google Scholar
• Englund JA, Zimmerman MK, Swierkosz EM, Goodman JL, Scholl DR, Balfour HH (1990): Herpes simplex virus resistant to acyclovir. Arch Inter Med 112: 416–422.
   Google Scholar
• Erlich KS, Mills J, Chatis P, Mertz GJ, Busch DF. Follansbee SE, Grant RM, Crumpacker CS (1989): Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. New Engl Med 320: 293–296.
   PubMed Web of Science ®Google Scholar
• Gong E, Matthews B, McCarthy T, Chua JH (2005): Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses. Antivir Res 68: 139–146.
   PubMed Web of Science ®Google Scholar
• Hai P, Zhou S, Shang H, Zhao G (1997): Antianoxic effects of Dracocephalum tanguticum on brain of mice. Zhong Yao Cai 20: 198–200.
   PubMedGoogle Scholar
• Han LS, Hu H, Wang F (2005): Protective effects of zang ying chen on liver and multiple organs injury by CCl4. J Med Pharm China Minorities 5: 20–21.
   Google Scholar
• Hook EW, Cannon RO, Nahmias AJ (1992): Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis 165: 251–255.
   PubMed Web of Science ®Google Scholar
• Jin L, Chen Z (2006): Anticancer research of Lagotis Brevituba Maxim. J Qinghai Normal University (Natural Science) 2: 86–87.
   Google Scholar
• Kuo YC, Chen CC, Tsai WJ, Ho YH (2001): Regulation of herpes simplex virus type 1 replication in Vero cells by Psychotria serpens: Relationship to gene expression, DNA replication, and protein synthesis. Antivir Res 51: 95–109.
   PubMed Web of Science ®Google Scholar
• Lapucci A, Macchia M, Parkin A (1993): Antiherpes virus agents: A review. Farmaco, IL. 245–260
   Google Scholar
• Li SY, Chen C, Zhang HQ, Guo HY, Wang H (2005): Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antivir Res 67: 18–23.
   PubMed Web of Science ®Google Scholar
• Lorke D (1983): A new approach to practical acute toxicity testing. Arch Toxicol 54: 275–287.
   PubMed Web of Science ®Google Scholar
• Lu M, Tian X (1999): Analysis of essential oil of Dracocephalum heterophyllum. Acta Pharma Sini. 34: 925–927.
   Google Scholar
• Luo DS (1997): Zhonghua Tibetan Herbal. Beijing, National Press, pp. 445–448.
   Google Scholar
• McGowan I (2006): Microbicides: A new frontier in HIV prevention. Biologicals 34: 241–255.
   PubMed Web of Science ®Google Scholar
• Nugier F, Collins JN, Langlois M (1992): Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: Report on a two-year sensitivity screening survey. J Med Virol 36: 1–12.
   PubMed Web of Science ®Google Scholar
• Mbopi-Keou, FX, Gresenguet Mayaud, P, Weiss, HA, Gopal R, Matta M, Paul, JL, Brown DWG, Hayes RJ, Mabey DCW, Belec L (2000): Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women. J Infect Dis 182: 1090–1096.
   PubMed Web of Science ®Google Scholar
• Mosmann T (1983): Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65: 55–63.
   PubMed Web of Science ®Google Scholar
• Rajcani J, Vojvodova A (1998): The role of herpes simplex virus glycoproteins in the virus replication cycle. Acta Virol 42: 103–118.
   PubMed Web of Science ®Google Scholar
• Shi GY, Lu RH (2003): Study on chemical constituents of essential oil from Lagotis brevituba. Nat Prod Res Dev 15: 23–28.
   Google Scholar
• Spear PG, Shieh MT, Herold BC, WuDunn D, Koshy TI (1992): Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus. Adv Exp Med Biol 313: 341–353.
   PubMedGoogle Scholar
• Schacker T (2001): The role of HSV in the transmission and progression of HIV. Herpes 8: 46–49.
   PubMedGoogle Scholar
• Sambrook J, Fritsch EF, Maniatis T (1989): Molecular Cloning: A Laboratory Manual. New York, Cold Spring Harbor Laboratory, pp. 851–862.
   Google Scholar
• Thi TN, Deback C, Malet I, Bonnafous P, Agut H (2006): Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR. Antivir Res 69: 152–157.
   PubMed Web of Science ®Google Scholar
• Whitley RJ, Kimberlin DW, Roizman B (1998): Herpes simplex viruses. Cli Infect Dis 26: 97–109.
   PubMed Web of Science ®Google Scholar
• Xue D, Yang F, Bee D (1994): Modification of the rabbit carotid body type I cell mitochondria by high altitude exposure and the effects of Dracocephalum heterophyllum. Adv Exp Med Biol 360: 357–360.
   PubMedGoogle Scholar
• Wang YB, Huang R, Zhang HB (2005): Diterpenoid alkaloid from Aconitum tanguticum. Helve Chimi Acta 88: 1081–1084.
   Web of Science ®Google Scholar
• Yang CM, Cheng HY, Lin TC, Chiang LC, Lin CC (2005): Acetone, ethanol and methanol extracts of Phyllanthus urinaria inhibit HSV-2 infection in vitro. Antivir Res 67: 24–30.
   PubMed Web of Science ®Google Scholar
• Zhang XF, Hu BL, Wang SX (1994): The chemical constituents from Dracocephalum tanguticum Maxim. Acta Bot Sini 36: 645–648.
   Google Scholar